Edgestream Partners L.P. Buys 127,430 Shares of Envista Holdings Co. (NYSE:NVST)

Edgestream Partners L.P. raised its holdings in Envista Holdings Co. (NYSE:NVST) by 520.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 151,925 shares of the company’s stock after purchasing an additional 127,430 shares during the quarter. Edgestream Partners L.P. owned 0.09% of Envista worth $3,002,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently bought and sold shares of the company. M&G Plc grew its stake in Envista by 12.5% in the 2nd quarter. M&G Plc now owns 306,253 shares of the company’s stock valued at $5,206,000 after purchasing an additional 33,923 shares during the period. Harbor Capital Advisors Inc. grew its stake in Envista by 287.4% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 169,648 shares of the company’s stock valued at $2,821,000 after purchasing an additional 125,861 shares during the period. Nuance Investments LLC grew its stake in Envista by 47.2% in the 2nd quarter. Nuance Investments LLC now owns 7,038,313 shares of the company’s stock valued at $117,048,000 after purchasing an additional 2,256,993 shares during the period. Sei Investments Co. grew its stake in Envista by 20.4% in the 2nd quarter. Sei Investments Co. now owns 925,170 shares of the company’s stock valued at $15,386,000 after purchasing an additional 157,048 shares during the period. Finally, WINTON GROUP Ltd bought a new position in Envista in the 2nd quarter valued at $7,019,000.

Analyst Upgrades and Downgrades

NVST has been the subject of a number of recent analyst reports. Stifel Nicolaus upped their price objective on Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 31st. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and upped their price target for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Bank of America dropped their price target on Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, August 8th. Finally, JPMorgan Chase & Co. cut Envista from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $23.00 to $16.00 in a research report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $20.71.

Envista Stock Performance

NYSE:NVST opened at $22.29 on Monday. The business’s 50-day moving average price is $19.79 and its two-hundred day moving average price is $18.28. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $25.64. The stock has a market cap of $3.84 billion, a P/E ratio of -2.87, a PEG ratio of 3.10 and a beta of 1.30. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm had revenue of $601.00 million for the quarter, compared to analysts’ expectations of $590.34 million. During the same quarter last year, the firm posted $0.43 EPS. The company’s revenue was down 4.8% compared to the same quarter last year. As a group, equities analysts predict that Envista Holdings Co. will post 0.72 EPS for the current fiscal year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.